tradingkey.logo
tradingkey.logo
Search

Progyny Inc

PGNY
Add to Watchlist
29.450USD
+0.620+2.15%
Close 07/01, 16:00ETQuotes delayed by 15 min
2.31BMarket Cap
36.51P/E TTM

More Details of Progyny Inc Company

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Progyny Inc Info

Ticker SymbolPGNY
Company nameProgyny Inc
IPO dateOct 25, 2019
CEOAnevski (Peter)
Number of employees675
Security typeOrdinary Share
Fiscal year-endOct 25
Address1359 Broadway
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10018
Phone12128883124
Websitehttps://www.progyny.com/
Ticker SymbolPGNY
IPO dateOct 25, 2019
CEOAnevski (Peter)

Company Executives of Progyny Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
11.27K
-10.95%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
5.38K
-15.24%
Mr. David Schlanger
Mr. David Schlanger
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Norman C. Payson, M.D.
Dr. Norman C. Payson, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--

FAQs

Who are the top five shareholders of Progyny Inc?

The top five shareholders of Progyny Inc are: Mr. Peter (Pete) Anevski

How many institutions hold shares of Progyny Inc (PGNY)?

As of 2026Q1, 790 institutions hold shares of Progyny Inc, with a combined market value of approximately 88.51M, accounting for 113.05% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -31976779.00.

What is the biggest source of revenue for Progyny Inc?

In 2026Q1, the Fertility benefits services revenue business generated the highest revenue for Progyny Inc, amounting to 830.93M and accounting for 64.48% of total revenue.